This HTML5 document contains 50 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
n21http://linked.opendata.cz/resource/drugbank/drug/DB02531/identifier/chemspider/
dctermshttp://purl.org/dc/terms/
n8http://linked.opendata.cz/resource/mesh/concept/
n20http://linked.opendata.cz/resource/drugbank/drug/DB02531/identifier/chebi/
n6http://linked.opendata.cz/resource/drugbank/drug/DB02531/identifier/wikipedia/
n12http://bio2rdf.org/drugbank:
n17http://linked.opendata.cz/resource/drugbank/drug/DB02531/identifier/kegg-compound/
n14http://linked.opendata.cz/resource/drugbank/drug/DB02531/identifier/pdb/
admshttp://www.w3.org/ns/adms#
n15http://linked.opendata.cz/resource/drugbank/drug/DB02531/identifier/pubchem-compound/
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n9http://linked.opendata.cz/resource/drugbank/drug/DB02531/identifier/pubchem-substance/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n7http://linked.opendata.cz/ontology/mesh/
owlhttp://www.w3.org/2002/07/owl#
n16http://linked.opendata.cz/resource/drugbank/drug/DB02531/identifier/iuphar/
n18http://linked.opendata.cz/resource/drugbank/drug/DB02531/identifier/drugbank/
n3http://linked.opendata.cz/ontology/drugbank/
n19http://linked.opendata.cz/resource/drugbank/drug/DB02531/identifier/guide-to-pharmacology/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB02531
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n12:DB02531 n13:DB02531
dcterms:title
Isobutyric Acid
adms:identifier
n6:Isobutyric_Acid n9:46506341 n14:ISB n15:6590 n16:1060 n17:C02632 n18:DB02531 n19:1060 n20:16135 n21:6341
n3:synonym
2-Methyl-propionic acid
n3:synthesisReference
Richard V. Norton, Lee R. Zehner, Ralph F. Pascoe, John E. Corn, Jr., Dace Grote, "Process for the production of isobutyric acid anhydride." U.S. Patent US4303594, issued September, 1936.
n7:hasConcept
n8:M0074033
n3:IUPAC-Name
n4:271B3FCB-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B3FD1-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B3FD0-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B3FCD-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B3FCE-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B3FCF-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B3FE0-363D-11E5-9242-09173F13E4C5 n4:271B3FC9-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B3FC7-363D-11E5-9242-09173F13E4C5 n4:271B3FCA-363D-11E5-9242-09173F13E4C5 n4:271B3FE3-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B3FE4-363D-11E5-9242-09173F13E4C5 n4:271B3FC8-363D-11E5-9242-09173F13E4C5
n3:pKa
n4:271B3FE5-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B3FD7-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B3FD8-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B3FD2-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B3FD3-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B3FD5-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B3FD4-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B3FD6-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
79-31-2
n3:Bioavailability
n4:271B3FDC-363D-11E5-9242-09173F13E4C5
n3:Boiling-Point
n4:271B3FE2-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B3FDE-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B3FDF-363D-11E5-9242-09173F13E4C5
n3:Melting-Point
n4:271B3FE1-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B3FDB-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B3FDA-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B3FDD-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B3FCC-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B3FD9-363D-11E5-9242-09173F13E4C5